NEW YORK (GenomeWeb News) — Dutch company Genmab has extended its agreement to use ID Business Solutions’ ActivityBase Xtended Edition screening software, Guildford, UK-based IDBS said today.
 
Under the agreement, Genmab’s Hybridoma Discovery department will use the software to mange the design, capture, storage, and retrieval of plate-based screening data, IDBS said.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.